Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/20/2025 | CALL | $70.00 | 5,139 | +929 | +22.07% |
| 06/20/2025 | PUT | $55.00 | 998 | +913 | +1,074.12% |
| 06/20/2025 | CALL | $80.00 | 10,152 | +262 | +2.65% |
| 06/20/2025 | PUT | $62.50 | 2,087 | +171 | +8.92% |
| 06/20/2025 | PUT | $60.00 | 1,275 | +61 | +5.02% |
| 05/16/2025 | CALL | $65.00 | 40 | +34 | +566.67% |
| 01/15/2027 | PUT | $125.00 | 0 | 0 | |
| 05/16/2025 | CALL | $70.00 | 2,615 | -1 | -0.04% |
| 05/16/2025 | CALL | $72.50 | 502 | -2 | -0.40% |
| 08/15/2025 | PUT | $60.00 | 537 | -2 | -0.37% |
| 05/16/2025 | PUT | $65.00 | 907 | -79 | -8.01% |
| 06/20/2025 | PUT | $65.00 | 4,205 | -253 | -5.68% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 3.08% | 4.2M | 85.34M |
| Vanguard Total Stock Market Index Fund | 3.02% | 4.11M | 83.55M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.72% | 3.71M | 75.31M |
| Vanguard Small-Cap Index Fund | 2.56% | 3.49M | 70.91M |
| iShares Russell 2000 ETF | 2.18% | 2.98M | 60.48M |
| Price (T.Rowe) Health Sciences Fund | 1.76% | 2.41M | 48.87M |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.67% | 2.27M | 46.14M |
| Price (T.Rowe) Small Cap Stock Fund | 1.59% | 2.17M | 44.02M |
| Vanguard Small-Cap Growth Index Fund | 1.48% | 2.02M | 40.97M |
| Price (T.Rowe) Small-Cap Value Fund | 1.44% | 1.97M | 40.04M |
Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight
01/21 02:00 pm
GlobeNewswire Inc.
Read moreEvolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
01/14 02:00 pm
GlobeNewswire Inc.
Read moreA Russell 2000 Bull Market Could Be Coming: 1 Spectacular BlackRock ETF to Buy Hand Over Fist Before It Gets Here
01/12 05:48 am
The Motley Fool
Read moreGroundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report
11/28 11:57 am
GlobeNewswire Inc.
Read moreHigh Levels of Cooperation, Care Drive Employees to Give Extra at the Best Small and Medium Workplaces
08/28 07:00 am
GlobeNewswire Inc.
Read moreInsmed Unusual Options Activity For July 11 - Benzinga
07/11 01:48 pm
Benzinga
Read moreWall Street Breakfast: The Week Ahead
06/30 09:10 am
Seeking Alpha
Read moreWall Street Breakfast: The Week Ahead
06/23 06:52 am
Seeking Alpha
Read moreInsmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
05/29 12:20 pm
Zacks Investment Research
Read moreInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
05/10 11:14 am
Zacks Investment Research
Read moreInsmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
05/09 10:00 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
05/09 08:15 am
Zacks Investment Research
Read moreShould You Buy Insmed (INSM) Ahead of Earnings?
05/08 10:19 am
Zacks Investment Research
Read moreWill Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
05/07 10:00 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
05/02 10:01 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
02/22 09:10 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
02/15 11:00 am
Zacks Investment Research
Read moreWhere Insmed Stands With Analysts
11/20 01:00 pm
Benzinga
Read moreAmgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/24 10:00 am
Zacks Investment Research
Read moreWill Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
10/19 10:02 am
Zacks Investment Research
Read moreWhere Insmed Stands With Analysts
09/06 11:00 am
Benzinga
Read moreInsmed (INSM) Up on Positive Data From MAC Lung Disease Study
09/06 07:46 am
Zacks Investment Research
Read moreWhy America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
09/05 01:34 pm
Benzinga
Read moreWhy Insmed Stock Is Soaring Today
09/05 11:52 am
The Motley Fool
Read moreBrady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
09/05 10:43 am
Benzinga
Read moreInsmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
08/03 09:05 am
Zacks Investment Research
Read moreG1 Therapeutics (GTHX) Tops Q2 Earnings and Revenue Estimates
08/02 07:45 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
07/26 11:00 am
Benzinga
Read moreInsmed (INSM) Reports Q1 Loss, Tops Revenue Estimates
05/04 08:55 am
Zacks Investment Research
Read moreRevance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
05/02 10:01 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
04/27 10:03 am
Zacks Investment Research
Read moreInsmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
02/23 10:15 am
Zacks Investment Research
Read moreY-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
02/16 11:01 am
Zacks Investment Research
Read moreInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
02/09 11:01 am
Zacks Investment Research
Read moreWall Street Analysts Believe Insmed (INSM) Could Rally 98.26%: Here's is How to Trade
01/24 10:55 am
Zacks Investment Research
Read moreBarclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
01/20 01:00 pm
Benzinga
Read moreAnalyst Expectations for Insmed's Future
01/20 09:00 am
Benzinga
Read moreCoupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
12/12 07:03 am
Benzinga
Read moreAnalyst Ratings for Insmed
12/07 08:02 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
11/18 12:58 pm
Benzinga
Read moreWhat 4 Analyst Ratings Have To Say About Insmed
11/18 12:05 pm
Benzinga
Read more$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying
11/03 09:49 am
Benzinga
Read moreInsmed (INSM) Reports Q3 Loss, Misses Revenue Estimates
10/27 08:45 am
Zacks Investment Research
Read moreVoyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Should You Buy?
10/25 10:01 am
Zacks Investment Research
Read moreWill Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
10/20 10:01 am
Zacks Investment Research
Read more